You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'HEK293'
> 95% as analyzed by SDS-PAGE and HPLC.
Approximately 75 kDa, consisting of a 306 amino acid residue p40 subunit and a 197 amino acid residue p35 subunit.
HEK 293
5 μg, 25 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
18-23 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
25~28 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg> 98% as analyzed by SDS-PAGE.
8.5 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg- RecombinantCT‑1,Mouse [orb1494652]
> 95% as analyzed by SDS-PAGE.
22~27 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg > 95% as analyzed by SDS-PAGE.
22~28 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg> 95% as analyzed by SDS-PAGE and HPLC.
19-24 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg- RecombinantVEGF-C,Human [orb1494619]
> 95% as analyzed by SDS-PAGE.
16~19 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg > 95% as analyzed by SDS-PAGE.
20~26 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg